Toxoplasma histone acetylation remodelers as novel drug targets
about
Lysine acetyltransferase GCN5b interacts with AP2 factors and is required for Toxoplasma gondii proliferationEpigenetic changes modulate schistosome egg formation and are a novel target for reducing transmission of schistosomiasisTgPRELID, a Mitochondrial Protein Linked to Multidrug Resistance in the Parasite Toxoplasma gondiiElongator protein 3 (Elp3) lysine acetyltransferase is a tail-anchored mitochondrial protein in Toxoplasma gondiiToxoplasma gondii Hsp90: potential roles in essential cellular processes of the parasite.In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents.Garcinol Inhibits GCN5-Mediated Lysine Acetyltransferase Activity and Prevents Replication of the Parasite Toxoplasma gondii.Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.A Systematic Review of In vitro and In vivo Activities of Anti-Toxoplasma Drugs and Compounds (2006-2016).Drugs in development for toxoplasmosis: advances, challenges, and current status.Effect of Nigella sativa oil on experimental toxoplasmosis.Modifications at K31 on the lateral surface of histone H4 contribute to genome structure and expression in apicomplexan parasites.An in silico pipeline to filter the Toxoplasma gondii proteome for proteins that could traffic to the host cell nucleus and influence host cell epigenetic regulation.
P2860
Q28538285-AD57D0B1-AEDE-4154-BD52-E277055D7E7AQ28538592-9ECCF5C2-F22D-4873-96A5-CA22655E01FCQ28817650-92458FB3-6AA7-4F8A-8873-FC4694447FF0Q30044490-CF2B7E14-974C-4C31-8CDE-65D6B782D064Q34273579-1BD54497-CBB2-4BC6-8132-3DAC2AA0C425Q34714738-42B63A7B-A5B0-4941-B6AA-2AF74AC391D0Q36729982-5C26C463-6B01-4CA9-BAE0-6E447095E315Q37428599-86A4D14F-5555-4AF6-8A69-DE34B34977C9Q37594988-BEC4C6D0-E267-49ED-BF9E-D79111C73799Q37613765-386CC24E-3F19-41AF-80F1-981A76BEF610Q40962264-553E3666-17B9-48A3-A231-660E1EB95756Q47159927-97AE6C95-FE6A-47AF-947E-908654BB5248Q55383167-7DC2A06C-8915-4D98-A664-A38B159C0A1D
P2860
Toxoplasma histone acetylation remodelers as novel drug targets
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Toxoplasma histone acetylation remodelers as novel drug targets
@ast
Toxoplasma histone acetylation remodelers as novel drug targets
@en
Toxoplasma histone acetylation remodelers as novel drug targets
@en-gb
Toxoplasma histone acetylation remodelers as novel drug targets
@nl
type
label
Toxoplasma histone acetylation remodelers as novel drug targets
@ast
Toxoplasma histone acetylation remodelers as novel drug targets
@en
Toxoplasma histone acetylation remodelers as novel drug targets
@en-gb
Toxoplasma histone acetylation remodelers as novel drug targets
@nl
prefLabel
Toxoplasma histone acetylation remodelers as novel drug targets
@ast
Toxoplasma histone acetylation remodelers as novel drug targets
@en
Toxoplasma histone acetylation remodelers as novel drug targets
@en-gb
Toxoplasma histone acetylation remodelers as novel drug targets
@nl
P2093
P2860
P356
P1476
Toxoplasma histone acetylation remodelers as novel drug targets
@en
P2093
Laura Vanagas
Maria C Dalmasso
Sergio O Angel
Silvina S Bogado
William J Sullivan
P2860
P304
P356
10.1586/ERI.12.100
P407
P577
2012-10-01T00:00:00Z